-
公开(公告)号:US20220153694A1
公开(公告)日:2022-05-19
申请号:US17593974
申请日:2020-04-16
发明人: Krzysztof KAMINSKI , Michal ABRAM , Marcin JAKUBIEC , Anna RAPACZ , Szczepan MOGILSKI , Gniewomir LATACZ , Marta STRUGA
IPC分类号: C07D207/27 , A61P25/28 , C07D207/404 , C07D207/416
摘要: 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives with R-configuration at the stereogenic center are disclosed, showing broad-spectrum protective activity in animal models of epileptic seizures, pain, depression and anxiety that are simultaneously devoid of undesirable sedative effects. Additionally, the disclosed derivatives have neuroprotective effects in the in vitro and in vivo studies.
-
2.
公开(公告)号:US20230192608A1
公开(公告)日:2023-06-22
申请号:US17996235
申请日:2021-04-16
发明人: Krzysztof KAMINSKI , Michal ABRAM , Marcin JAKUBIEC , Anna RAPACZ , Szczepan MOGILSKI , Gniewomir LATACZ , Marta STRUGA
IPC分类号: C07D207/263 , C07D207/416
CPC分类号: C07D207/263 , C07D207/416
摘要: Water-soluble analogs of compounds intended for the treatment of neurological diseases, epilepsy, neuropathic pain and migraine, and psychiatric disorders, including anxiety and depression, especially suitable for the preparation of oral or parenteral drug forms, are disclosed.
-